Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

NCT01379209 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: RGI-2001
DRUG: Calcineurin Inhibitors
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Conditioning Regimen
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Methotrexate
DRUG: Mofetil Mycophenolate
DRUG: sirolimus

Sponsor

Regimmune Corporation